Preeclampsia is one of the “great obstetrical syndromes” in which multiple and sometimes
overlapping pathologic processes activate a common pathway consisting of endothelial cell …

Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …

Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and
proteinuria after 20 weeks of gestation, is the leading cause of maternal and perinatal …

The established method of the assessment of the risk for development of preeclampsia is to
identify risk factors from maternal demographic characteristics and medical history; in the …

Metformin is everywhere. Originally introduced in clinical practice as an antidiabetic agent,
its role as a therapeutic agent is expanding to include treatment of prediabetes mellitus …

Effective screening for the development of early onset preeclampsia (PE) can be provided in
the first‐trimester of pregnancy. Screening by a combination of maternal risk factors, uterine …

Pre-eclampsia (PE) is a leading cause of maternal and fetal/neonatal morbidity and mortality
worldwide. Clinical diagnosis and definition of PE is commonly based on the measurement …

Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate
biomarkers have been proposed for diagnosis and prediction of preeclampsia …

Despite the fact that the estrogenic effects of bisphenols were first described 80 years ago,
recent data about its potential negative impact on birth outcome parameters raises a strong …

Background Among women with hypertensive disorders of pregnancy, biomarkers may
stratify risk for developing preeclampsia with severe features (sPE). Methods Across 18 US …